2014 Neuropsychopharmacology Reviews: Biomolecular Discovery: Mechanisms, Therapeutics, and Biomarkers in Neural Disorders



Frontiers of Biomolecular Exploration in Brain Disorders FREE

Carol L Nilsson and Kathryn A Cunningham

Neuropsychopharmacology 39: 1-4; doi:10.1038/npp.2013.262


Review Articles

Integrative Biological Analysis For Neuropsychopharmacology FREE

Mark R Emmett, Roger A Kroes, Joseph R Moskal, Charles A Conrad, Waldemar Priebe, Fernanda Laezza, Anke Meyer-Baese and Carol L Nilsson

Neuropsychopharmacology 39: 5-23; advance online publication, August 28, 2013; doi:10.1038/npp.2013.156

Mass Spectrometry Strategies for Clinical Metabolomics and Lipidomics in Psychiatry, Neurology, and Neuro-Oncology FREE

Paul L Wood

Neuropsychopharmacology 39: 24-33; advance online publication, August 14, 2013; doi:10.1038/npp.2013.167

Mass Spectrometry Imaging, an Emerging Technology in Neuropsychopharmacology FREE

Mohammadreza Shariatgorji, Per Svenningsson and Per E Andrén

Neuropsychopharmacology 39: 34-49; advance online publication, September 25, 2013; doi:10.1038/npp.2013.215

Small-Volume Analysis of Cell–Cell Signaling Molecules in the Brain FREE

Elena V Romanova, Jordan T Aerts, Callie A Croushore and Jonathan V Sweedler

Neuropsychopharmacology 39: 50-64; advance online publication, July 3, 2013; doi:10.1038/npp.2013.145

Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness FREE

Robert E McCullumsmith, John H Hammond, Dan Shan and James H Meador-Woodruff

Neuropsychopharmacology 39: 65-87; advance online publication, October 30, 2013; doi:10.1038/npp.2013.239

An Integrated Quantitative Proteomics and Systems Biology Approach to Explore Synaptic Protein Profile Changes During Morphine Exposure FREE

Steven D Stockton Jr and Lakshmi A Devi

Neuropsychopharmacology 39: 88-103; advance online publication, October 23, 2013; doi:10.1038/npp.2013.227

Proteomic Approaches and Identification of Novel Therapeutic Targets for Alcoholism FREE

Giorgio Gorini, R Adron Harris and R Dayne Mayfield

Neuropsychopharmacology 39: 104-130; advance online publication, September 25, 2013; doi:10.1038/npp.2013.182

Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field FREE

Kjell Fuxe, Dasiel O Borroto-Escuela, Wilber Romero-Fernandez, Miklós Palkovits, Alexander O Tarakanov, Francisco Ciruela and Luigi F Agnati

Neuropsychopharmacology 39: 131-155; advance online publication, October 9, 2013; doi:10.1038/npp.2013.242

Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance FREE

Melissa L Perreault, Ahmed Hasbi, Brian F O'Dowd and Susan R George

Neuropsychopharmacology 39: 156-168; advance online publication, July 10, 2013; doi:10.1038/npp.2013.148

Regenerative Therapies for Central Nervous System Diseases: a Biomaterials Approach FREE

Roger Y Tam, Tobias Fuehrmann, Nikolaos Mitrousis and Molly S Shoichet

Neuropsychopharmacology 39: 169-188; advance online publication, October 9, 2013; doi:10.1038/npp.2013.237

Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease FREE

Kaj Blennow, Harald Hampel and Henrik Zetterberg

Neuropsychopharmacology 39: 189-201; advance online publication, July 17, 2013; doi:10.1038/npp.2013.154

Biomarkers for the Development of New Medications for Cocaine Dependence FREE

Kristopher J Bough, Shashi Amur, Guifang Lao, Scott E Hemby, Nilesh S Tannu, Kyle M Kampman, Joy M Schmitz, Diana Martinez, Kalpana M Merchant, Charles Green, Jyoti Sharma, Anne H Dougherty and F Gerard Moeller

Neuropsychopharmacology 39: 202-219; advance online publication, October 9, 2013; doi:10.1038/npp.2013.210



Revitalizing Psychiatric Therapeutics FREE

Steven E Hyman

Neuropsychopharmacology 39: 220-229; doi:10.1038/npp.2013.181

Innovation in Therapeutics Development at the NCATS FREE

Christine M Colvis and Christopher P Austin

Neuropsychopharmacology 39: 230-232; doi:10.1038/npp.2013.247


Hot Topics

Neurobiology of Rapid Acting Antidepressants: Role of BDNF and GSK-3β FREE

Ronald S Duman and George K Aghajanian

Neuropsychopharmacology 39: 233; doi:10.1038/npp.2013.217

Seeing the Future: Epigenetic Biomarkers of Postpartum Depression FREE

Zachary Kaminsky and Jennifer Payne

Neuropsychopharmacology 39: 234; doi:10.1038/npp.2013.238

Cell Adhesion Molecules: Druggable Targets for Modulating the Connectome and Brain Disorders? FREE

George R Uhl and Jana Drgonova

Neuropsychopharmacology 39: 235; doi:10.1038/npp.2013.240

Circuits in Sync: Decoding Theta Communication in Fear and Safety FREE

Ekaterina Likhtik and Joshua A Gordon

Neuropsychopharmacology 39: 236; doi:10.1038/npp.2013.228

Toward Identification of Neural Markers of Suicide Risk in Adolescents FREE

Lisa A Pan and Mary L Phillips

Neuropsychopharmacology 39: 237; doi:10.1038/npp.2013.233

Reduced Cocaine Reinforcement in the Male Offspring of Cocaine-Experienced Sires FREE

R Christopher Pierce and Fair M Vassoler

Neuropsychopharmacology 39: 238; doi:10.1038/npp.2013.234

De Novo Mutations in Schizophrenia Disrupt Genes Co-Expressed in Fetal Prefrontal Cortex FREE

Suleyman Gulsuner and Jon M McClellan

Neuropsychopharmacology 39: 238-239; doi:10.1038/npp.2013.219

Repetitive Transcranial Magnetic Stimulation as a Treatment for Auditory Hallucinations FREE

Iris E Sommer and Sebastian FW Neggers

Neuropsychopharmacology 39: 239-240; doi:10.1038/npp.2013.225

Error-Related Brain Activity as a Biomarker for Cocaine Relapse FREE

Reshmi Marhe and Ingmar Franken

Neuropsychopharmacology 39: 241; doi:10.1038/npp.2013.245

Parkinson's Disease Biomarkers: Resources for Discovery and Validation FREE

Mark Frasier and Un Jung Kang

Neuropsychopharmacology 39: 241-242; doi:10.1038/npp.2013.246

Neurotherapeutic Implications of Brain-Immune Interactions FREE

Jennifer C Felger and Andrew H Miller

Neuropsychopharmacology 39: 242-243; doi:10.1038/npp.2013.213

Neuronal Primary Cilia: An Underappreciated Signaling and Sensory Organelle in the Brain FREE

Jill A Green and Kirk Mykytyn

Neuropsychopharmacology 39: 244-245; doi:10.1038/npp.2013.203

When Synaptic Proteins Meet the Genome: Transcriptional Regulation in Cell Death and Plasticity by the Synapto–Nuclear Messenger Jacob FREE

Sujoy Bera and Michael R Kreutz

Neuropsychopharmacology 39: 245-246; doi:10.1038/npp.2013.204

Maintaining and Modifying Connections: Roles for Axon Guidance Cues in the Mature Nervous System FREE

Greta Thompson-Steckel and Timothy E Kennedy

Neuropsychopharmacology 39: 246-247; doi:10.1038/npp.2013.212

Functional Selectivity at GPCRs: New Opportunities in Psychiatric Drug Discovery FREE

Steven D Chang and Michael R Bruchas

Neuropsychopharmacology 39: 248-249; doi:10.1038/npp.2013.205

Obesity, Food, and Addiction: Emerging Neuroscience and Clinical and Public Health Implications FREE

Marc N Potenza

Neuropsychopharmacology 39: 249-250; doi:10.1038/npp.2013.198

Targeting Emotion Circuits with Deep Brain Stimulation in Refractory Anorexia Nervosa FREE

Nir Lipsman and Andres M Lozano

Neuropsychopharmacology 39: 250-251; doi:10.1038/npp.2013.244

Proteomic Biomarkers for Brain Disorders: Technical Considerations and Challenges FREE

Linda S Brady and William Z Potter

Neuropsychopharmacology 39: 252; doi:10.1038/npp.2013.202

Main navigation

ACNP resources

NPG resources

Extra navigation

21 November 2019